![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Novartis future growth prospects secured by industry-leading pipeline
Novartis has provided an update on its leading Research and Development (R&D) pipeline and...
Scientists test 5,000 combinations of 100 existing cancer drugs to find more effective treatments
Scientists in the United States have tested all possible pairings of the 100 cancer...
New drug significantly lowers bad cholesterol
For many people with high cholesterol, statins serve as the first line of treatment....
Results from the largest known cholesterol survey conducted in the U.S.
Results from the USAGE survey, the largest known cholesterol survey in the U.S. involving...
FDA expands use of Xarelto to treat, reduce recurrence of blood clots
The U.S. Food and Drug Administration expanded the approved use of Xarelto (rivaroxaban) to...
Boehringer Ingelheim presents robust pipeline highlighting its Respiratory R&D
At its 3rd International Research & Development press conference, Boehringer Ingelheim unveiled a pipeline...
Novartis to start construction of new biotechnology facility in Singapore
Novartis announced the construction of a new state-of-the-art biotechnology production site in Singapore with...
Antibiotic shows promise in treating extensively drug-resistant tuberculosis
When tested in patients hospitalized with extensively drug-resistant tuberculosis (XDR-TB) unresponsive to previous treatment,...
New malaria drug requires just one dose and appears twice as effective as existing...
Scientists are reporting development of a new malaria drug that, in laboratory tests, has...
Cold viruses point the way to new cancer therapies
Cold viruses generally get a bad rap - which they've certainly earned - but...